Delivery Order SPE2DB20D2014-SPE2DB24FA60H
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,908.27 firm fixed-price delivery order is for the AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML pharmaceutical product, with a period of performance through April 2, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,657.95, is for the delivery of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a pharmaceutical product. The contract has a period of performance through February 5, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,479.28, is for the delivery of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price and has an ultimate completion date of June 10, 2024. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a...
- This federal contract award, valued at $1,055.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a pharmaceutical product, with a completion date of March 8, 2024. The contract is a delivery order type, with a firm fixed price pricing structure. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML pharmaceutical products. The contract has a potential value of $1,055.52 and a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The contract is one of multiple delivery orders issued...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,076.64 firm fixed-price contract is for the supply of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a pharmaceutical product, with a period of performance through March 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is a delivery order valued at $1,055.52, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML pharmaceutical products, with a completion date of March 4, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not designated as a set-aside contract. The company holds an indefinite delivery contract...
- This federal contract award, valued at $1,055.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the pharmaceutical product AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, with an ultimate completion date of November 15, 2024. The contract utilizes a Firm Fixed Price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML pharmaceutical products. The $1,952.94 contract has a completion date of February 5, 2024. Amerisourcebergen Drug Corp serves as the prime contractor and is not operating under a set-aside designation. This award is issued under a larger indefinite delivery contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,355.91 firm fixed-price delivery order is for the supply of 225 mg/1.5 ml AJOVY auto-injector products. The contract has an ultimate completion date of June 4, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FA60HDelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $7,928.87, is for the delivery of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 15, 2023. The award was made on December 14, 2022 and is not designated as a set-aside contract. AmerisourceBergen Drug Corp is the prime contractor and there are no major subcontractors mentioned. This contract is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 12/14/23 |